Is Generation Bio Co (NASDAQ: GBIO) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

GBIO belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Generation Bio Co is $78.89M. A total of 1.06 million shares were traded on the day, compared to an average of 251.65K shares.

In the most recent transaction, Paone Antoinette sold 6,719 shares of GBIO for 2.74 per share on Jul 01 ’24. After the transaction, the CHIEF OPERATING OFFICER now owns 13,807 company shares.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, GBIO has a high of $4.65 and a low of $0.75.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. GBIO’s latest balance sheet shows that the firm has $375.14M in Cash & Short Term Investments as of fiscal 2021. There were $80.83M in debt and $18.81M in liabilities at the time. Its Book Value Per Share was $1.56, while its Total Shareholder’s Equity was $381.75M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for GBIO is Buy with a score of 4.00.

Most Popular

Related Posts